Thomas Rodolpho Kotarakos
Chief Financial OfficerMr. Thomas Rodolpho Kotarakos, also known as Tom, is Chief Financial Officer of Parabilis Medicines, Inc. from February 2026. Mr. Kotarakos was Executive Vice President of Finance of Parabilis Medicines, Inc. from March 2023 to February 2026. He had been Senior Vice President of Finance at Fog Pharmaceuticals, Inc. until March 2023. He joined Parabilis Medicines, Inc. in December 2021. Most recently, he was the SVP of Finance and Business Operations at Codiak BioSciences from December 2018 to December 2021 where he oversaw the Finance, Accounting, IT and Facilities functions. While at Codiak, he helped drive the S-1, banking and legal processes tied to IPO filing, while transitioning the accounting function to a public-company posture Prior to this, he held various roles at Seres Therapeutics where he guided the accounting and finance functions through the IPO process; implemented process and controls necessary to operate as a public company; and owned Accounting, Accounts Payable and Insurance and Treasury. Before his time at Seres, he held a few different roles at GT Advance Technologies and PricewaterhouseCoopers where he spent several years, focused on the life sciences. He is a CPA and received his MS and BS in Accounting from Bentley University.
Positions
- Company NameParabilis Medicines, Inc.Stock CodePBLSPositionChief Financial OfficerColleagues
- MMMathai MammenCEO, President, Treasurer & Chairman
- TLTeresa L. JurgensenExecutive VP, Secretary & General Counsel
- JMJohn McGeeScientific Co-Founder, Executive Vice President & Head of Platform
- RMRohin MhatreChief Technical Operations Officer
- KYKrishna YeshwantIndependent Non-Employee Director
- EMEdward M. FitzgeraldIndependent Non-Employee Director
- AAAlexis A. BorisyIndependent Non-Employee Director
- BLBarbara L. WeberIndependent Non-Employee Director
